Endologix (ELGX) Misses Q2 EPS by 2c, Beats on Revenues

Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $48.6 million versus the consensus estimate of $47.62 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery